Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

449
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
449
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

930
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
930
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

486
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
486
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

838
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
838
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

536
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
536

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening for protein energy wasting in children with chronic kidney disease using dual energy x-ray absorptiometry as an additional tool.

Pediatric nephrology (Berlin, Germany)·2023
Same author

Urinary protein to creatinine ratio during the first month of life in very preterm infants-a prospective cohort study (PROTIPREMA).

Pediatric nephrology (Berlin, Germany)·2022
Same author

Correction to: When the progresses in neonatology lead to severe congenital nephron deficit: is there a pilot in the NICU?

Pediatric nephrology (Berlin, Germany)·2022
Same author

When the progresses in neonatology lead to severe congenital nephron deficit: is there a pilot in the NICU?

Pediatric nephrology (Berlin, Germany)·2021
Same author

Prevalence and subtypes of hypertension in normal-weight and obese Indian adolescents: a cross-sectional study.

Journal of human hypertension·2021
Same author

Clinico-pathological Profile and Outcome of C-3 Glomerulopathy in Indian Children.

Indian journal of nephrology·2021

Related Experiment Video

Updated: Jan 24, 2026

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
06:46

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure

Published on: December 22, 2023

1.1K

Acute Renal Failure in the Neonate.

Jean-Pierre Guignard1, Uma S Ali2

  • 1Department of Pediatrics, CHUV, Lausanne University, Medical School, Lausanne, Switzerland.

Journal of Pediatric Intensive Care
|May 22, 2019
PubMed
Summary

Acute renal failure (ARF) in neonates is common, with nonoliguric ARF showing a better prognosis. Management varies by type, including fluid balance for prerenal, obstruction relief for postrenal, and renal replacement therapy for intrinsic ARF.

Keywords:
asphyxic renal failureneonatal nephrologyneonatal renal failurenephrotoxic drugs

More Related Videos

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.2K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.9K

Related Experiment Videos

Last Updated: Jan 24, 2026

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
06:46

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure

Published on: December 22, 2023

1.1K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.2K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.9K

Area of Science:

  • Nephrology
  • Neonatology
  • Pediatric Critical Care

Background:

  • Acute renal failure (ARF) is a significant clinical challenge in high-risk neonates.
  • ARF presents as oliguric or nonoliguric, with nonoliguric forms generally indicating a better prognosis.
  • Identified risk factors include prematurity, cardiorespiratory and vascular issues, congenital anomalies, and exposure to nephrotoxic agents.

Purpose of the Study:

  • To outline the diagnostic approaches and management strategies for acute renal failure in the neonatal population.
  • To differentiate between prerenal, intrinsic, and postrenal causes of ARF.
  • To discuss the various therapeutic options, including conservative management and renal replacement therapies.

Main Methods:

  • Urine chemical analysis and ultrasonography are key diagnostic tools.
  • Classification of ARF into prerenal, intrinsic, and postrenal categories guides treatment.
  • Management strategies involve fluid and electrolyte balance, obstruction relief, and renal replacement therapy.

Main Results:

  • Prerenal ARF management focuses on optimizing cardiac output and fluid/electrolyte homeostasis.
  • Severe postrenal ARF necessitates prompt relief of urinary tract obstruction.
  • Intrinsic ARF often requires renal replacement therapy, with peritoneal dialysis being the preferred method.

Conclusions:

  • The prognosis of neonatal ARF is closely linked to the underlying cause and severity of renal injury.
  • Timely diagnosis and appropriate management are crucial for improving outcomes in neonates with ARF.
  • Peritoneal dialysis is the primary renal replacement therapy for intrinsic ARF, though other modalities may be considered.